NCT00417170: Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic Syndrome |
|
|
| Completed | 2 | 48 | US | Aliskiren, Amlodipine, Placebo Aliskiren, Placebo Amlodipine | Novartis Pharmaceuticals | High Blood Pressure, Metabolic Syndrome, Insulin Resistance, Endothelial Dysfunction | 07/10 | 07/10 | | |
